However, nothing has been reported i) on the effectiveness of these peptides on other CFTR variants, including those that severely affect the mechanism of channel opening (like G551D), along with their plausible mode of action, or ii) their antimicrobial activity in conditions mimicking CF-lung. This evidence concerns the gene CFTR and cystic fibrosis.